AAAAAA

   
Results: 1-3 |
Results: 3
CARBOPLATIN HYPERSENSITIVITY REACTIONS IN PATIENTS WITH OVARIAN AND PERITONEAL CARCINOMA
Authors: ROSE PG FUSCO N FLUELLEN L RODRIGUEZ M
Citation: Pg. Rose et al., CARBOPLATIN HYPERSENSITIVITY REACTIONS IN PATIENTS WITH OVARIAN AND PERITONEAL CARCINOMA, International journal of gynecological cancer, 8(5), 1998, pp. 365-368
96-HOUR INFUSIONAL PACLITAXEL AS SALVAGE THERAPY OF OVARIAN-CANCER PATIENTS PREVIOUSLY FAILING TREATMENT WITH 3-HOUR OR 24-HOUR PACLITAXEL INFUSION REGIMENS
Authors: MARKMAN M ROSE PG JONES E HOROWITZ IR KENNEDY A WEBSTER K BELINSON J FUSCO N FLUELLEN L KULP B PETERSON G MCGUIRE WP
Citation: M. Markman et al., 96-HOUR INFUSIONAL PACLITAXEL AS SALVAGE THERAPY OF OVARIAN-CANCER PATIENTS PREVIOUSLY FAILING TREATMENT WITH 3-HOUR OR 24-HOUR PACLITAXEL INFUSION REGIMENS, Journal of clinical oncology, 16(5), 1998, pp. 1849-1851
2ND-LINE THERAPY WITH PACLITAXEL AND CARBOPLATIN FOR RECURRENT DISEASE FOLLOWING FIRST-LINE THERAPY WITH PACLITAXEL AND PLATINUM IN OVARIANOR PERITONEAL CARCINOMA
Authors: ROSE PG FUSCO N FLUELLEN L RODRIGUEZ M
Citation: Pg. Rose et al., 2ND-LINE THERAPY WITH PACLITAXEL AND CARBOPLATIN FOR RECURRENT DISEASE FOLLOWING FIRST-LINE THERAPY WITH PACLITAXEL AND PLATINUM IN OVARIANOR PERITONEAL CARCINOMA, Journal of clinical oncology, 16(4), 1998, pp. 1494-1497
Risultati: 1-3 |